DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
PF-00610355 is an investigational drug.
There have been 4 clinical trials for PF-00610355. The most recent clinical trial was a Phase 2 trial, which was initiated on April 15th 2009.
The most common disease conditions in clinical trials are Lung Diseases, Lung Diseases, Obstructive, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for PF-00610355
|A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers||Pfizer||Phase 1|
|A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.||Pfizer||Phase 2|
|A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects||Pfizer||Phase 2|